Issue No. 56 • Tuesday August 11, 2026 The Trading Addict Newsletter by Maria Helmick  Tap the image to view full size Maria's Market Brief · Stock in Focus · ORCL Oracle's Monday Rally: Turnaround or Just a Bounce?Dip-buyers stepped in, but Oracle's AI ambitions, balance-sheet pressure and damaged chart are still competing for investors' attention. | Market Snapshot ORCL rose about 1.9% to $149.75, outperforming the broader market during Monday's session. |
Oracle gained nearly 2% Monday as dip-buyers stepped in, outperforming the broader market despite continuing concerns about the company's debt-funded AI expansion. Oracle is investing heavily in AI data centers, creating a potentially powerful growth opportunity — but at a significant cost. The company ended fiscal 2026 with negative free cash flow, elevated capital spending and approximately $260 billion in data-center lease obligations. In July, S&P Global Ratings lowered Oracle's credit rating to BBB-, just one notch above speculative grade. The longer-term chart remains weak. Oracle is down more than 40% over the past 12 months and continues to trade below its major moving averages: $159.21 (50-day), $164.43 (100-day) and $178.69 (200-day). Until the stock can reclaim those levels, Monday's rally looks more like a bounce than a confirmed turnaround. Next Major Catalyst: Earnings Sept. 8Wall Street expects earnings of $1.67 per share on revenue of $19.13 billion. Management's comments about AI demand, capital spending, debt and cash flow could determine whether this rebound has staying power. Analysts remain divided. UBS: Buy, $245 target. CLSA: Hold, $145 target. Bernstein: Outperform, $325 target. Maria's Bottom Line Oracle is a trickster stock. It can reward you quickly, pull you in and then reverse before you realize the game has changed. My preferred entry was $114.50, and I missed it. With earnings approaching, I'll keep watching — but I will not chase the stock on an upswing. Lesson learned: Don't fall in love with the stock. Take the profit and move on. |
|
Market Brief · Space Earnings Q2 2026 Space Earnings: Growth Meets GravityBoth companies showed substantial long-term demand, but investors focused on near-term execution: Rocket Lab's margins and Neutron schedule, and AST SpaceMobile's widening losses. | Q2 revenue rose 62% year over year to a record $234 million, while backlog reached $2.36 billion. Looking ahead, management forecast Q3 GAAP gross margins of 29%–31%, below Wall Street's 37.6% estimate. Neutron is expected to reach the launch pad in Q4, but management said the window for a 2026 launch is narrowing. AST SpaceMobile (ASTS) | -4.4% close |
ASTS maintained its 2026 revenue outlook of $150 million–$200 million. Q2 net loss attributable to common shareholders widened to $230.9 million, or $0.77 per share, from $99.4 million ($0.41) a year earlier. The wider loss overshadowed progress on the satellite network. The regular-session decline occurred before results; shares weakened further after hours. Sources: company Q2 releases and filings; Reuters. Market moves are preliminary. For informational purposes only. |
Market Intelligence · AI Infrastructure LITE Exploded — So Where Does the AI Money Go Next?The next AI money may follow the bottlenecks — memory, optics and inference — where expensive processors need faster data, better connections and more efficient workloads. | Phil Blancato, Chief Market Strategist at Osaic, is focused on the next stage of the AI buildout. The first race was about getting enough GPUs. Now the challenge is keeping those GPUs fed, connected and working efficiently. That is pushing spending toward memory, optics and inference — technologies designed to remove the next set of AI bottlenecks. Marvell is targeting the memory problem created by increasingly complex AI workloads. Lumentum (LITE) is benefiting from the shift toward optical connections that can move enormous amounts of data quickly through AI systems. NVIDIA's strategic investment in Lumentum earlier this year reinforced just how important optics is becoming. $66.24 May 2025 | $1,085.68 Record High | ~$813 Current Area | +1,539% Low to High |
LITE may be one of the best examples of how quickly Wall Street can reprice a company when it becomes central to the AI story. From $66.24 in May 2025 to $1,085.68 — roughly a +1,539% move. Even after pulling back to around $813, it remains up more than 1,100% from that May 2025 level. Another catalyst is coming: Lumentum reports earnings Aug. 11 after the market closes. After a move this large, the numbers are only part of the story. Guidance on AI demand, optical capacity and cloud spending could matter just as much — and the reaction could be fast in either direction. Maria's Bottom Line I can't help but feel like I missed the boat on LITE. After a move from $66.24 to more than $1,085, I'm not interested in jumping aboard this late and finding out the hard way that the ship has already sailed — or worse, started taking on water. The bigger opportunity may be finding the next company solving the next big AI problem before everyone else piles in. And if you happen to find the next 1,500% AI runner before Wall Street does, my inbox is always open. |
|
» MARKET TIDBIT  Tap the tidbit to view full size » DAY 203 · MON AUG 10 · DAILY TRADING UPDATE  Tap the dashboard to see the full summary online  » Tap to watch the live daily show at 9:15 AM and 3:25 PM Monday through Friday, as well as Sunday at 5:55 PM ET » TRADES OF THE WEEK Week of August 10 — Two SPX 0DTE trades | | Entry Time | Strategy | | 11:25 | 225 M 95 50 00 | | 15:23 | 225 M 95 50 00 |
Two SPX 0DTE plays — same 225 M 95 50 00 strategy, morning and afternoon. |
Free Community Join our Discord with over 1,000 like-minded traders who believe that math makes money when it comes to trading Trade ideas, screenshots, daily banter. Zero cost. Join the Discord → |
MATH MAKES MONEY Rob and Maria Helmick and Nick Battista · The Trading Addict Newsletter MathMakesMoney.com Educational only. Not investment advice. Trading options involves substantial risk. Past performance does not guarantee future results. |
|